Abstract
The interleukin-2 is a cytokine that is essential for lymphocytic survival and function. Ectopic expression of the IL-2 receptor in epithelial tissues has been reported previously, although the functional significance of this expression is still being investigated. We provided novel structural and functional information on the expression of the IL-2 receptor in kidney cancer cells and in other normal and neoplastic human epithelial tissues. In A-498 kidney cancer cells, we showed that IL-2 binding to its own receptor triggers a signal transduction pathway leading to the inhibition of proliferation and apoptosis. We found that the inhibition of proliferation is associated with Erk1/2 dephosphorylation, whereas the survival signals appear to be mediated by Sgk1 activation. This investigation focuses on the IL-2 induced regulation of Sgk1 and describes a role of the IL-2 receptor and Sgk1 in the regulation of epithelial tumor cell death and survival.
Similar content being viewed by others
Abbreviations
- IL-2:
-
Interleukin-2
- IL-2R:
-
Interleukin-2 Receptor
- Sgk1:
-
Serum and glucocorticoid regulated kinase
- Erk1/2:
-
Extracellular regulated kinase 1/2
- Shc-1:
-
Src homology 2 domain containing
References
David D, Bani L, Moreau JL, Treilhou MP, Nakarai T, Joussemet M, Ritz J, Dupont B, Pialoux G, Theze J (1998) Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc Natl Acad Sci USA 95:11348–11353
Upton MP, Parker RA, Youmans A, McDermott DF, Atkins MB (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28:488–495
Bazan JF (1992) Unraveling the structure of IL-2. Science 257:410–412
Kelly E, Won A, Refaeli Y, Van Parijs L (2002) IL-2 and related cytokines can promote T cell survival by activating AKT1. J Immunol 168:597–603
Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952–965
Kobayashi T, Cohen P (1999) Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 339:319–328
Perrotti N, He RA, Phillips SA, Haft CR, Taylor SI (2001) Activation of serum-and glucocorticoid-induced protein kinase (Sgk) by cyclic AMP and insulin. J Biol Chem 276:9406–9412
Frodin M, Antal TL, Dummler BA, Jensen CJ, Deak M, Gammeltoft S, Biondi RM (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J 21:5396–5407
Menniti M, Iuliano R, Amato R, Boito R, Corea M, Le Pera I, Gulletta E, Fuiano G, Perrotti N (2005) Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells. Am J Physiol Cell Physiol 288:C148–C155
Leong ML, Maiyar AC, Kim B, O’Keeffe BA, Firestone GL (2003) Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 278:5871–5882
Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL (1996) p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem 271:12414–12422
Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD (2004) Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64:1757–1764
Zheng, Li D-C, Zhang Z-D, Zhao J, Ge J-F (2005) Anti-gastric cancer active immunity induced by FasL/B7-1gene-modified tumor cells. World J Gastroenterol 11:3204–3211:1757–1764
Suminami Y, Kashii Y, Law JC, Lin WC, Stanson J, Reichert TE, Rabinowich H, Whiteside TL (1988) Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells. Oncogene 16:1309–1317
Christoffersen CT, Bornefeldt KE, Rotella CM, Gonzales N Vissing H, Shymko RM, Hoeve JT, Groffen J, Heisterkamp N, De Meyts P (1994) Negative cooperativity in the insulin-like growth factor-I receptor and a chimeric IGF-I/insulin receptor. Endocrinology 1:472–475
Shikama Y, U M, Miyashita T, Yamada M (2001) Comprehensive studies on subcellular localization and cell death inducing activities of eight GFP-tagged apoptosis related caspase. Exp Cell Res 264:315–325
Waldegger S, Barth P, Raber G, Lang F (1997) Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA 94:4440–4445
Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, Wagner S, Wolf M, Hunig T (2002) IL-2 and autoimmune disease. Cytokine Growth Factor Rev 13:369–378
Lesur O, Brisebois M, Thibodeau A, Chagnon F, Lane D, Fullop T (2004) Role of IFN-gamma and IL-2 in rat lung epithelial cell migration and apoptosis after oxidant injury. Am J Physiol Lung Cell Mol Physiol 286:L4–L14
Fukushima K, Hara-Kuge S, Ideo H, Yamashita K (2001) Carbohydrate recognition site of interleukin-2 in relation to cell proliferation. J Biol Chem 276:31202–31208
Sharon M, Siegel JP, Tosato G, Yodoi J, Gerrard TL, Leonard WJ (1988) The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med 167:1265–1270
Weissman AM, Harford JB, Svetlik PB, Leonard WL, Depper JM, Waldmann TA, Greene WC, Klausner RD (1986) Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci USA 83:1463–1466
Wang Xi, Rickert M, Garcia KC (2005) Structure of the quaternary complex of interleukin-2 with its, ß, and χc receptors. Science 310:1159–1163
Kradin RL, Xia W, Pike M, Byers HR, Pinto C (1996) Interleukin-2 promotes the motility of dentric cells and their accumulation in lung and skin. Pathobiology 64:180–186
Thèze J, Alzari PM, Bortoglio J (1996) Intereleukin 2 and its receptor recent advances and new immunological functions. Immunol Today 17:481–484
Reinecker HC, Podolsky D (1995) Human intestinal epithelial cells express functional cytokine receptor sharing the common γc chain oh the IL-2 receptor. Proc Natl Acad Sci USA 92:8353–8357
McMillian DN, Kernohan NM, Flett ME, Heys SD, Deehan DJ, Sewell HF, Walker F, Eremin O (1995) Interleukin-2 receptor expresion in human solid tumor cells in situ and in vitro: evidence for a direct role in regulation of tumor cell proliferation. Int J Cancer 60:766–772
Vamosi G, Bodnar A, Vereb G, Jenei A, Goldman CK, Langowski J, Toth K, Matyus L, Szollosi J, Waldmann TA, Damjanovich S (2004) IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci USA 101:11082–11087
Robb RJ, Greene WC, Rusk CM (1984) Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med 160:1126–1146
Gesbert F, Sauvonnet N, Dautry-Varsat A (2004) Clathrin-independent endocytosis and signalling of interleukin 2 receptors IL-2R endocytosis and signalling. Curr Top Microbiol Immunol 286:119–148
Morrone G, Bond HM, Cuomo C, Agosti V, Petrella A, Pagnano AM, Della Corte A, Marasco O, Venuta S (1995) Differential regulation of the expression of interleukin-2 receptor gamma-chain during the in vitro differentiation of human myeloid cells. Biochem J 308:909–914
Romerio F, Zella D (2002) MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J 16:1680–1682
Faletti CJ, Perrotti N, Taylor SI, Blazer-Yost BL (2002) sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am J Physiol Cell Physiol 282:C494–C500
Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H, Asano T (2003) Differing roles of Akt and serum and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 278:25802–25807
Vallon V, Lang F (2005) New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure. Curr Opin Nephrol Hypertens 14:59–66
Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T (2005) Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer 117:738–745
Biondi RM, Kieloch A, Currie RA, Deak M, Alessi DR (2001) The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20:4380–4390
Lang F, Cohen P (2001) Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Science’s Signal Transduct Knowledge Environment 108:RE17
Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA (1999) Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18:3024–3033
Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol 7:261–269
Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH, Hahne M, Beermann F, Attinger A, Orbea HA, Budd RC, Tschopp J (2002) The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 22:5419–5433
Boehrer S, Kukoc-Zivojnov N, Nowak D, Bergmann M, Baum C, Puccetti E, Weidmann E, Hoelzer D, Mitrou PS, Chow KU (2004) Upon drug-induced apoptosis expression of prostate-apoptosis-response-gene-4 promotes cleavage of caspase-8, bid and mitochondrial release of cytochrome c. Hematology 9:425–431
Chen JS, Konopleva M, Andreeff M, Multani AS, Pathak S, Mehta K (2004) Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol 200:223–234
Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y, Terachi T, Ogawa O (2002) Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Int J Oncol 20:949–954
Tangir J, Bonafe N, Gilmore-Hebert M, Henegariu O, Chambers SK (2004) SGK1, a potential regulator of c-fms related breast cancer aggressiveness. Clin Exp Metastasis 21:477–483
Buse P, Tran SH, Luther E, Phu PT, Aponte GW, Firestone GL (1999) Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways. J Biol Chem 274:7253–7263
Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F (1999) h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 116:1081–1088
Li W, Wang S, Chen C, Zhuang G (2006) Induction of tumor cell apoptosis via Fas/DR5. Cell Mol Immunol 3:467–471
Schickling O, Stegh AH, Byrd J, Peter ME (2001) Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ 8:1157–1168
Ferrando-May E (2005) Nucleocytoplasmic transport in apoptosis. Cell Death Differ 12:1236–1276
Besnault-Mascard L, Leprince C, Auffredou MT, Meunier B, Bourgeade MF, Camonis J, Lorenzo HK, Vazquez A (2005) Caspase-8 sumoylation is associated with nuclear localization. Oncogene 24:3268–3273
Nelson BH, Martyak TP, Thompson LJ, Moon JJ, Wang T (2003) Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol 170:5563–5570
Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A (2005) Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111:1652–1659
Acknowledgments
We thank Charity Nofziger and Professor Bonnie Blazer-Yost for critical reading and helpful discussion of the manuscript, and Nicola Amodio for the caspase 8 confocal experiment’s acquisition.
This work was supported by Fondazione Carical, Cluster 04 work package 6A, Cofin 2003/20032003063143_003, Cofin 2005 /068017_004, Interlink II04C0G4EM.
Author information
Authors and Affiliations
Corresponding author
Additional information
In loving memory of Salvatore Venuta, 1944–2007.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Amato, R., Menniti, M., Agosti, V. et al. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. J Mol Med 85, 707–721 (2007). https://doi.org/10.1007/s00109-007-0205-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-007-0205-2